Literature DB >> 26138842

Osteoporosis in Children with Chronic Disease.

Wolfgang Högler1, Leanne Ward.   

Abstract

Serious illness in children and its therapy can cause osteoporosis, manifesting as vertebral and nonvertebral fractures, pain, skeletal deformity and temporary or even permanent loss of ambulation. In contrast to adults, skeletal growth in children offers tremendous potential to recover bone mineral density and to reshape fractured vertebral bodies, even without bone-targeted therapy, provided that bone health threats are transient and residual growth is sufficient. Here, we outline the principles of bone strength development and the risk factors for osteoporosis due to various paediatric systemic illnesses. We also explain why the approach to the diagnosis and monitoring of childhood osteoporosis has moved away from a bone density-centric focus to a more functional assessment. Finally, we discuss the best candidates for and current approaches to the treatment of osteoporosis in children.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26138842     DOI: 10.1159/000381045

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  9 in total

1.  Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.

Authors:  Ping Yang; Shan Lv; Yan Wang; Yi Peng; Zixing Ye; Zhuying Xia; Guoxian Ding; Xu Cao; Janet L Crane
Journal:  Bone       Date:  2018-05-23       Impact factor: 4.398

2.  The time to and determinants of first fractures in boys with Duchenne muscular dystrophy.

Authors:  J Ma; H J McMillan; G Karagüzel; C Goodin; J Wasson; M A Matzinger; P DesClouds; D Cram; M Page; V N Konji; B Lentle; L M Ward
Journal:  Osteoporos Int       Date:  2016-10-24       Impact factor: 4.507

Review 3.  Denosumab: an Emerging Therapy in Pediatric Bone Disorders.

Authors:  Alison M Boyce
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

4.  Glucocorticoids Disrupt Skeletal Angiogenesis Through Transrepression of NF-κB-Mediated Preosteoclast Pdgfb Transcription in Young Mice.

Authors:  Yi Peng; Shan Lv; Yusheng Li; Jianxi Zhu; Shijie Chen; Gehua Zhen; Xu Cao; Song Wu; Janet L Crane
Journal:  J Bone Miner Res       Date:  2020-03-11       Impact factor: 6.741

5.  The use of quantitative ultrasound in a tertiary-level children hospital: role in the follow-up of chronically ill patients.

Authors:  Albina Tummolo; Giacomina Brunetti; Mario Giordano; Vincenza Carbone; Maria Felicia Faienza; Maurizio Aricò; Sabino Pesce
Journal:  J Ultrasound       Date:  2022-01-29

6.  Spontaneous reshaping of vertebral fractures in an adolescent with osteogenesis imperfecta.

Authors:  Rodrigo Montero-Lopez; Elisabeth Laurer; Katharina Tischlinger; Dóra Nagy; Mario Scala; Wolfgang Kranewitter; Gerald Webersinke; Thomas Hörtenhuber; Wolfgang Högler
Journal:  Bone Rep       Date:  2022-06-03

Review 7.  Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management.

Authors:  Francesca Di Marcello; Giulia Di Donato; Debora Mariarita d'Angelo; Luciana Breda; Francesco Chiarelli
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

8.  Common Variants in OPG Confer Risk to Bone Mineral Density Variation and Osteoporosis Fractures.

Authors:  Xiaoyong Sheng; Guangyong Cai; Xingjun Gong; Zouying Yao; Ye Zhu
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

9.  Cherubism as a systemic skeletal disease: evidence from an aggressive case.

Authors:  Anne Morice; Aline Joly; Manon Ricquebourg; Gérard Maruani; Emmanuel Durand; Louise Galmiche; Jeanne Amiel; Yoann Vial; Hélène Cavé; Kahina Belhous; Marie Piketty; Martine Cohen-Solal; Ariane Berdal; Corinne Collet; Arnaud Picard; Amelie E Coudert; Natacha Kadlub
Journal:  BMC Musculoskelet Disord       Date:  2020-08-21       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.